Literature DB >> 16299400

Chromogranin A transcription and gene expression in Folliculostellate (TtT/GF) cells inhibit cell growth.

Gail A Stilling1, Jill M Bayliss, Long Jin, Heyu Zhang, Ricardo V Lloyd.   

Abstract

Folliculostellate (FS) cells are present in the anterior pituitary and have important regulatory functions including controlling hormone release from other anterior pituitary cells. FS cells do not usually express neuroendocrine genes such as chromogranin A (CgA). We analyzed transcriptional regulation and gene expression in the TtT/GF FS cell line to better understand the role of FS cells in anterior pituitary function. After transient transfection with a human (h) CgA promoter sequence linked to a luciferase reporter, there was basal level of transcriptional activity, which was two- to fourfold less than that observed in the anterior pituitary neuroendocrine cell lines HP75 and GH3. The transcriptional activity was decreased in all cell lines when a mutant hCgA promoter cyclic AMP response element (CRE) was used for transfection. Sodium butyrate treatment increased the transcriptional activity in all cell lines, but remained two- to fourfold higher in the HP75 and GH3 cell lines than in the TtT/GF cells. Stable transfection of a plasmid expressing bovine (b) CgA in the TtT/GF cells led to inhibition of cell growth as measured by 3H-thymidine incorporation, Ki-67 labeling index, and growth curve analysis. CgA protein and mRNA could be readily demonstrated in the cloned cells but not in the parental cell line or vector control cells. When the CgA expressing cloned cells were injected into SCID mice, there was a decrease in the rate of tumor growth compared to the vector control in vivo. These results indicate that the TtT/GF FS cells are fibroblast-like compared to the neuroendocrine anterior pituitary secretory cells when analyzed by transcriptional activity with a transiently transfected CgA promoter. In TtT/GF cells with a stably transfected bCgA plasmid, CgA has a direct regulatory effect on tumor cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299400     DOI: 10.1385/ep:16:3:173

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  44 in total

1.  Genes modulated by histone acetylation as new effectors of butyrate activity.

Authors:  F Della Ragione; V Criniti; V Della Pietra; A Borriello; A Oliva; S Indaco; T Yamamoto; V Zappia
Journal:  FEBS Lett       Date:  2001-06-22       Impact factor: 4.124

2.  Analysis of homogeneous populations of anterior pituitary folliculostellate cells by laser capture microdissection and reverse transcription-polymerase chain reaction.

Authors:  L Jin; I Tsumanuma; K H Ruebel; J M Bayliss; R V Lloyd
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

3.  Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes.

Authors:  Carmen González-Yanes; Víctor Sánchez-Margalet
Journal:  Biochem Biophys Res Commun       Date:  2002-12-13       Impact factor: 3.575

4.  Localization of the secretory granule marker protein chromogranin B in the nucleus. Potential role in transcription control.

Authors:  Seung Hyun Yoo; Soon Hee You; Moon Kyung Kang; Yang Hoon Huh; Choong Sik Lee; Chan Seob Shim
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

5.  Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.

Authors:  L Jin; W F Chandler; J B Smart; B G England; R V Lloyd
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

Review 6.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

7.  Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.

Authors:  B H Fasciotto; C A Trauss; G H Greeley; D V Cohn
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

Review 8.  Chromogranin A.

Authors:  G N Hendy; S Bevan; M G Mattei; A J Mouland
Journal:  Clin Invest Med       Date:  1995-02       Impact factor: 0.825

Review 9.  Histone deacetylase. A key enzyme for the binding of regulatory proteins to chromatin.

Authors:  G López-Rodas; G Brosch; E I Georgieva; R Sendra; L Franco; P Loidl
Journal:  FEBS Lett       Date:  1993-02-15       Impact factor: 4.124

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more
  3 in total

1.  The characteristic change in the distribution of S-100 immunoreactive folliculostellate cells in rat anterior pituitary upon long-term estrogen treatment is prevented by concomitant progesterone treatment.

Authors:  Andrea Heinzlmann; Katalin Köves
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

Review 2.  Formation of secretory granules by chromogranins.

Authors:  Chie Inomoto; Robert Yoshiyuki Osamura
Journal:  Med Mol Morphol       Date:  2009-12-24       Impact factor: 2.309

3.  Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors.

Authors:  Gail A Stilling; Heyu Zhang; Katharina H Ruebel; Alexey A Leontovich; Long Jin; Yoshinori Tanizaki; Shuya Zhang; Lori A Erickson; Timothy Hobday; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2007       Impact factor: 4.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.